(NBC Bay Area 5/31/2013)
Dancin' Power gets patients moving - even those stuck in bed - and serves as a welcome distraction and creative outlet during hospitalization and outpatient treatment
(San Francisco Chronicle 5/15/2013)
The San Francisco Chronicle
's in-depth report on MPS IV ("Morquio") clinical trial at Children's Oakland. Dr. Paul Harmatz runs the potentially life-changing BioMarin trial for children from all over the world for treatment of the rare, inherited metabolic disorder.
(San Francisco Chronicle 5/1/2013)
Nonprofit Rooms That Rock 4 Chemo volunteers did a colorful weekend makeover of Children's Outpatient Infusion Center complete with painted walls, themed rooms, new curtains, and art. Patients with chronic illnesses including blood disorders and cancer visit the Outpatient Infusion Center for treatment, sometimes as frequent as once a week.
(San Francisco Chronicle 4/22/2013)
In 1983, when bone marrow transplants were rare and experimental, a Bay Area family's journey to raise funds to pay for their 2 year old's transplant for cancer captivated media. Today, the sister and then-5 year old bone marrow donor, Krista, is a registered nurse in Children's Immunocompromised Unit, caring for children undergoing blood and bone marrow transplants to cure cancer and blood disorders.
Diagnosed with the life-threatening blood disorder, aplastic anemia, adopted 5 year old Colin was reunited at Children's Oakland with his birth brother from Vietnam for a life-saving bone marrow transplant.
Children's is the only Unites States site for an international drug trial examining the use of an iron chelator to treat a rare and devastating neurodegenerative disorder, PKAN. Director of Hematology/Oncology Elliott Vichinsky, MD, has been treating two patients with the drug and seen marked improvement, including regaining the ability to speak and walk, is the trial's Principal Investigator. Though the disease is rare, the implications of the research extend to other neurodegerative disorders involving brain iron accumulation including Parkinson's and Alzheimer's diseases.
Research shows that like medicine, music therapy has a physiological effect. Children's Oakland's Music Therapy program, staffed by music therapists who work with hospitalized patients, is featured at the 17:50 timestamp of this segment.
(San Francisco Business Times 3/6/2013)
Children's and Bayer HealthCare have entered a collaborative agreement to utilize research and help identify new therapies for rare blood diseases including sickle cell disease. The collaboration includes clinical care led by hematologist/oncologist Elliott Vichinsky, MD, and research led by CHORI scientist Frans Kuypers, PhD.
(Oakland Tribune 2/9/2013)
Asthma is the #1 chronic illness for children, and it's on the rise. The Oakland Tribune
explores what asthma means for thousands of Bay Area kids who, despite daily medication, still wind up in the hospital for days from exposure to pollution, a virus, or even dust mites. Children's Oakland clinicians, patients, and doctors, including hospitalist Ted Chaconas, MD, are featured in this article and the accompanying video.
Barbara Staggers, MD, MPH, Adolescent Medicine director and VP of External Affairs and Community Relations, is the new chair of The California Wellness Foundation's Board of Directors.